MetLife Investment Management’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
|
|||||
|
2025
Q4 | $266K | Sell |
|
|||||
|
2025
Q3 | $267K | Sell |
|
|||||
|
2025
Q2 | $142K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $12.8K | Sell |
|
|||||
|
2022
Q3 | $415K | Buy |
|
|||||
|
2022
Q2 | $258K | Sell |
|
|||||
|
2022
Q1 | $306K | Buy |
|
|||||
|
2021
Q4 | $256K | Buy |
|
|||||
|
2021
Q3 | $210K | Sell |
|
|||||
|
2021
Q2 | $199K | Buy |
|
|||||
|
2021
Q1 | $103K | Sell |
|
|||||
|
2020
Q4 | $222K | Hold |
|
|||||
|
2020
Q3 | $285K | Hold |
|
|||||
|
2020
Q2 | $299K | Buy |
|
|||||
|
2020
Q1 | $199K | Hold |
|
|||||
|
2019
Q4 | $307K | Hold |
|
|||||
|
2019
Q3 | $330K | Buy |
|
|||||
|
2019
Q2 | $221K | Buy |
|